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Abstract
Background: Idiopathic focal dystonia is a motor syndrome associated with dysfunction of basal ganglia circuits. Observations have suggested that many other
non-motor symptoms may also be part of the clinical picture. The aim was to assess the prevalence and correlation of non-motor symptoms in patients with
common idiopathic focal or segmental dystonia.
Methods: In a single-center cross-sectional case–control study, we evaluated the presence of pain, neuropsychiatric symptoms, and sleep alterations in 28 patients
with blepharospasm, 28 patients with cervical dystonia, 24 patients with writer’s cramp, and 80 control subjects matched for sex, age, and schooling. We obtained
clinical and demographic data, and evaluated patients using the Fahn–Marsden Dystonia Rating Scale and other specific scales for dystonia. All subjects completed
the following questionnaires: Beck Depression Inventory, Beck Anxiety Inventory, Social Phobia Inventory, Apathy Scale, Epworth Sleepiness Scale, Pittsburgh
Sleep Quality Index, Brief Pain Scale, and the World Health Organization Quality of Life brief scale.
Results: The patients presented more symptoms of depression, anxiety, and apathy than the control subjects. They also reported worse quality of sleep and more
pain complaints. Patients with blepharospasm were the most symptomatic subgroup. The patients had worse quality of life, and the presence of pain and symptoms
of apathy and depression were the main influences for these findings, but not the severity of motor symptoms.
Discussion: Patients with dystonia, especially those with blepharospasm, showed higher prevalence of symptoms of depression, anxiety, apathy, worse quality of
sleep, and pain. These symptoms had a negative impact on their quality of life.
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Introduction
Dystonia is a movement disorder characterized by sustained and/
or intermittent muscle contractions causing abnormal, often repe-
titive, movements, postures, or both.1 Focal isolated dystonia is the
most common form of dystonia in adulthood, with symptom onset
usually in the fifth decade of life. Most of these cases are idiopathic
and may present as cervical dystonia, blepharospasm, or writer’s
cramp.2 Idiopathic focal dystonia in adults rarely progresses to
generalized dystonia, but may spread to contiguous regions and
become a segmental form.3 Despite the localized distribution of
abnormal movements, focal dystonia affects functional aspects
of daily living and social functioning, and significantly impairs
quality of life.4
Although dystonia presents characteristically as a clinical motor
problem, many studies have suggested that several non-motor symptoms
can often be observed in these patients and may be relevant predictors
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of their quality of life.4,5 Among these, some neuropsychiatric symp-
toms such as depression, anxiety, apathy, and obsessive–compulsive
behaviors can be highlighted. Additionally, these patients also report
having sleep disorders and pain.6–8 These non-motor symptoms
might be because dystonia may cause functional disability and nega-
tive body perception, which could lead to the appearance of symptoms
of anxiety and depression. On the other hand, non-motor symptoms
may relate primarily to the pathophysiology of dystonia itself.
The pathophysiology of dystonia is not completely understood, but
is considered to be related to dysfunctions of the basal ganglia system
and its connections, mainly to the thalamus and brainstem.9 It has
also been correlated with dysfunction of the cerebellum, one of the most
prominent brain structures associated with motor control.10 Further-
more, several non-motor symptoms of dystonia may be due to abnormal
functioning of cortical, limbic, basal ganglionic, and cerebellar loops.
Most studies published so far have focused only on a specific group of
non-motor symptoms, without assessing the correlations between the
most prevalent ones, and some have reported contrary findings.11 Since
these symptoms can significantly influence patients’ quality of life, it
is extremely important to gain better understanding of this issue. The
present study aimed to evaluate the prevalence of neuropsychiatric
symptoms, sleep disturbances, and pain in a sample of patients with
idiopathic focal or segmental dystonia, and to investigate correlations
between these symptoms and their impact on quality of life.
Methods
Participants
This was a case–control cross-sectional single-center study con-
ducted on Brazilian patients. For our study, we initially recruited 160
participants. Out of that group, 80 were control subjects. The remain-
ing 80 participants were consecutive patients with various forms
of idiopathic focal or segmental dystonia. All participants were over
18 years old. The exclusion criteria in both groups were the presence
of dementia, any other neurological disorder or any serious or decom-
pensated systemic disease.
Patients were recruited from the outpatient clinic for movement
disorders at the Ribeira˜o Preto School of Medicine. All participants
agreed to participate in this study. They were all diagnosed with a
common form of adult-onset idiopathic focal or segmental dystonia,
with confirmation from a movement disorder specialist. All patients
who were regularly undergoing treatment with botulinum toxin type A
were evaluated at least 13 weeks after the last application. In addition,
if the patient was using any other medication for dystonia, the treat-
ment was continued.
The control group was matched for sex, age, and years of education
(schooling). Control participants were selected from among the indivi-
duals who accompanied the patients with movement disorders to their
appointments and from among hospital staff members. The objective
of the study was explained to these individuals and they were asked if
they were willing to voluntarily collaborate in the study as a control
group to be compared with the patients in the study. The exclusion
criteria were the same as in the group of patients, but individuals with
pathological conditions were not excluded, even if chronic, if that con-
dition was adequately controlled; those with previous psychiatric
conditions were not excluded. If a participant in the control group
presented altered scores on the scales evaluated, this individual would
be referred for medical follow-up.
This study was approved by the local Ethics Committee of the
Ribeira˜o Preto School of Medicine hospital (protocol number 12736/
2011) and was conducted in accordance with the ethical principles of
the Declaration of Helsinki. All subjects signed an informed consent
statement before participating.
Measurements
A clinical evaluation was conducted by a neurologist who was a
specialist in movement disorders in order to obtain clinical and demo-
graphic data from the patients and control subjects. The severity of
dystonia was determined using the Fahn–Marsden Dystonia Rating
Scale.12 We evaluated patients with blepharospasm using the Jankovic
Rating Scale and the Blepharospasm Disability Index,13 patients with
cervical dystonia using the Tsui Rating Scale,14 and patients with
writer’s cramp using the Writer’s Cramp Rating Scale and the Arm
Dystonia Disability Scale.15,16
We assessed non-motor symptoms using clinical scales that had been
validated for the Brazilian population. Cognition was assessed by
means of the Mini Mental State Examination.17 The Beck Depression
Inventory (BDI) and Beck Anxiety Inventory (BAI) were used to
determine self-reported levels of depression and anxiety.18,19 The
Social Phobia Inventory was used to identify subjects with suspected
social phobia.20 Symptoms of apathy were evaluated using the Apathy
Scale (AS).21
Excessive daytime sleepiness was assessed using the Epworth Sleep-
iness Scale.22 Sleep quality was evaluated using the Pittsburgh Sleep
Quality Index (PSQI).23
We evaluated the presence of pain over the previous 3 months by
using a structured questionnaire based on the Brief Pain Scale24
(prevalence, monthly frequency, intensity according to a numerical
visual scale, and site affected according to a drawing of the specific
location). The World Health Organization Quality of Life brief scale
(WHOQOL-BREF) was used to evaluated quality of life.25
All subjects were evaluated in either one or two sessions. They were
initially instructed to provide self-reported responses to the question-
naires. The examiner then checked the responses and, if necessary (in
cases in which patients were unable to respond to all the questions or if
there were any doubts), the questionnaire was reapplied. In cases of ina-
bility to use self-reported scales (due to severe dystonia or low education
levels), a trained examiner applied the instruments to the subject.
Statistics
We performed descriptive analysis on all the clinical data. For com-
parisons between groups, two comparative analyses were performed.
Firstly, we compared all the patients versus the control group. To
compare numerical variables, we used analysis of variance, followed by
the Bonferroni post hoc test when appropriate. For categorical data,
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we used the exact chi-square test and odds ratio estimates through
binary logistic regression.
We then compared all three subtypes of dystonia with the controls,
simultaneously. Non-adjustment was made with regard to matching
for sex, age, and schooling levels between these groups. In this analysis,
we used multivariate analysis of covariance, followed by the Bonferroni
post hoc test when appropriate. The factors analyzed were groups and
sex, as categorical variables, and age and schooling as numerical
covariates. For the categorical data, we used the exact chi-square test
and odds ratio estimates through binary logistic regression.
The Spearman rank correlation test was used to evaluate asso-
ciations between the motor scales.
The data were expressed as mean¡SD, and p , 0.05 was assumed
to be statistically significant. The data were analyzed using SPSS 17.0
statistical software (IBM, USA).
Results
We evaluated 80 patients and 80 control subjects. The patients
group consisted of 28 patients with blepharospasm, including five
patients with cranial dystonia (group 1); 28 patients with cervical
dystonia, including five patients with craniocervical dystonia (group 2);
and 24 patients with limb dystonia, including 22 with writer’s cramp,
one with leg dystonia and one with arm dystonia (group 3). Table 1
presents the clinical characteristics and demographic data on all the
patients and control subjects.
Comparing all the patients with the control group, there were no
significant differences between the groups according to age, gender,
schooling, or Mini-Mental State Examination scores. The patients had
presented dystonia for 10–15 years and were using antidepressants
more frequently than were the controls (p 5 0.038).
Both the majority of patients (n 5 41) and the majority of
participants in the control group (n 5 55) had at least one comorbidity
(p 5 0.024). Cardiovascular diseases were predominant in both groups
with comorbidities of patients (58.5%) and control participants (63.6%)
(p 5 0.612), followed by endocrine and metabolic diseases (46.3% and
38.2%, respectively, p 5 0.422), and neuropsychiatric diseases (39%
and 23.6%, p 5 0.104).
We found significant differences between the groups regarding their
scores from the BDI, BAI, AS, PSQI, and Numerical Visual Scale for
pain; however, there were no differences between the groups regarding
their scores from the Social Phobia Inventory and Epworth Sleepiness
Scale (Table 1).
In the BDI, the patients had higher scores than the controls. They
presented more than twice the risk of having a depressive symptom
(BDI > 12) (p 5 0.004; odds ratio [OR] 5 2.58; 95% confidence
interval [CI] 5 1.32–5.04), and more of them presented moderate and
severe depressive symptoms (BDI > 20) (p 5 0.024). They also
presented higher scores in the BAI than did the controls, with a higher
chance of presenting a symptom of anxiety (BAI > 8) (p 5 0.001;
OR 5 3.58; 95% CI 5 1.67–7.67).
From analysis of the AS, the patients showed significantly higher
scores (p 5 0.002) and their risk of apathy (AS > 14) was three times
higher than that of the controls (p 5 0.002; OR 5 2.96; 95% CI 5
1.49–5.87). Moreover, they presented higher scores in the PSQI than
did the controls, and their sleep quality was more frequently impaired
(PSQI . 5) than was that of the controls (p 5 0.007; OR 5 2.37; 95%
CI 5 1.25–4.47). Multivariate regression analysis showed that the BDI
and BAI scores (p 5 0.004 and p, 0.001) influenced the PSQI scores,
whereas there was no effect on pain (p 5 0.485) or the use of anti-
depressants among the subjects (p 5 0.730).
The dystonic patients presented significantly more intense and
frequent pain than did the controls. They were 2.5 times more likely to
complain of pain than were the controls (p5 0.019; OR 5 2.58; CI5
1.16–5.71). Most of those with cervical dystonia (87%) and writer’s
cramp (76%) reported having pain at the site of their dystonic move-
ments, while most of the patients with blepharospasm (67%) reported
having pain in other parts of the body.
The patients with dystonia presented lower total scores in the
WHOQOL-BREF measurement than those of the controls (Table 1).
They showed lower scores in physical and psychological evaluations,
but not in the social relationship or environmental domains. In
multivariate analysis, the presence of pain (p 5 0.029), BDI scores
(p , 0.001), AS scores (p , 0.001), and type of dystonia (p 5 0.015)
influenced the WHOQOL-BREF total score, but there was no
influence on the severity of motor symptoms measured by the Fahn–
Marsden Dystonia Rating Scale (p 5 0.198).
Comparing the patient subgroups with the control group, group 3
was the only group in which males predominated. Group 1 was signi-
ficantly older, with lower schooling and lower Mini-Mental State
Examination scores than either of the other two subgroups of patients
or the controls. Schooling (p , 0.001) and age (p 5 0.046) influenced
the Mini-Mental State Examination scores of the patients, but there
was no influence from the type of dystonia (p 5 0.854).
The Fahn–Marsden Dystonia Rating Scale scores correlated
significantly with the scores on the scores on the Jankovic Rating Scale
(p 5 0.0001; correlation coefficient (cc) 5 0.71), Arm Dystonia
Disability Scale (p 5 0.0001; cc 5 –0.77), Writer’s Cramp Rating
Scale part B (p 5 0.01; cc 5 –0.53), and Tsui Rating Scale (p 5 0.02;
cc 5 –0.42). However, there were no correlations with the scores
on the Blepharospasm Disability Index (p 5 0.15; cc 5 0.27) or the
Writer’s Cramp Rating Scale part A (p 5 0.15; cc 5 –0.31). These
observations suggest that the scores on the Fahn–Marsden Dystonia
Rating Scale generally reflected the severity of dystonia in the
different groups of patients. Group 1 and group 2 did not show any
difference in their Fahn–Marsden Dystonia Rating Scale scores,
while group 3 presented lower scores than either of the other
subgroups (p 5 0.013).
In a group analysis, we found that the prevalence of psychiatric
symptoms presented by group 3 was not as high as the prevalence
among the patients in groups 1 and 2. Group 1 had higher BDI scores
than those of all the other groups. They also showed higher BAI and
AS scores than those of group 3 and the controls (Table 2).
Group 1 was five times more likely to experience pain than
were the controls (p 5 0.006; OR 5 5.38; 95% CI 5 1.63–17.78).
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Their risk of having pain symptoms was higher than that observed
for group 2 (p 5 0.005; OR 5 4.63; 95% CI 5 1.59–13.49) or
group 3 (p 5 0.056; OR 5 2.72; 95% CI 5 0.97–1.02). The Fahn–
Marsden Dystonia Rating Scale scores did not affect the results
from the BDI and BAI, AS, or PSQI (p 5 0.328), or the presence of
pain (p 5 0.250).
Group 2 showed higher BAI scores and higher AS scores than the
controls. Groups 2 and 3 presented higher PSQI scores than the
controls (Table 2).
From analysis on all the different subgroups, we observed that group 1
was the most affected in terms of quality of life, which includes the
physical and social relationship domains. Groups 1 and 2 were equally
Table 1. Demographic and Clinical Characteristics of 80 Patients with Focal and Segmental Idiopathic Dystonia and 80 Control Subjects
Patients Control Subjects p
Total Total
Number 80 80 –
Gender (M/F) 29/51 29/51 –
Age (years) 58.8¡14.2 56.5¡13.3 0.298
Schooling (years) 9.1¡6.1 9.5¡4.8 0.550
% with comorbidities 51.2 68.7a 0.024
% with use of benzodiazepines 18.7 11.2 0.184
% with use of antidepressants 23.7a 11.2 0.038
Duration of disease (years) 12.8¡9.7 – –
Age at disease presentation 45.8¡13.3 – –
FMDRS scores 5.5¡3.3 – –
MMSE 25.90¡3.16 26.55¡2.93 0.180
BDI 12.64¡10.83a 9.05¡7.32 0.015
BAI 10.40¡9.22a 6.33¡8.86 0.005
AS 13.89¡8.37a 10.08¡6.62 0.002
SPIN 17.98¡13.63 14.33¡12.02 0.074
ESS 7.89¡4.72 8.85¡4.82 0.204
PSQI 7.51¡4.1a 5.91¡4.17 0.017
Pain, NVS scores 6.6¡2.5a 5.3¡2.4 0.018






















Abbreviations: AS, Apathy Scale; BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; ESS, Epworth Sleepiness Scale; FMDRS,
Fahn–Marsden Dystonia Rating Scale; MMSE, Mini Mental State Examination; NVS, Numeric Visual Scale; PSQI, Pittsburgh Sleep Quality
Index; SPIN, Social Phobia Inventory; WHOQOL-BREF, World Health Organization Quality of Life Brief Scale.
Data were compared using analysis of variance and chi-square.
aDifferent from the other group (p # 0.05).
Novaretti N, Cunha ALN, Bezerra TC, et al. Idiopathic Focal and Segmental Dystonia
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org Columbia University Libraries4
affected in regard to the physical domain compared with the controls,
while group 3 was the least affected in all domains (Table 2).
Discussion
Our study confirmed previously published observations that indi-
cated that non-motor symptoms are more prevalent in patients with
idiopathic focal or segmental dystonia. Our patients with blephar-
ospasm, cervical dystonia, and writer’s cramp presented more symp-
toms of depression, anxiety, apathy, pain, and impaired sleep quality
than did the control subjects. Nonetheless, despite having poor sleep
quality, they did not complain of excessive daytime sleepiness. In addi-
tion, even though they showed more anxiety symptoms, the incidence
of social phobia was not higher.
Several studies have already indicated that the prevalence of
depressive symptoms in patients with dystonia is higher, thus indicating
that depression is probably a common clinical problem associated with
this disorder.6,8,11,26 However, for some authors, the association
between dystonia and anxiety was not very well defined.11
In our sample, patients with focal dystonia presented significantly more
symptoms of anxiety than did the controls. This was also observed in
some other recent studies.7,8,26 Only one study did not find any
association between symptoms of anxiety and dystonia.6 Despite these
contradictory findings, most recent studies corroborate the notion that
there is an association between dystonia and symptoms of anxiety. We did
not find higher levels of symptoms of social phobia among our patients;
however, there was a statistical trend towards this. Other studies have also
indicated a high frequency of social phobia among patients with cervical
dystonia.27,28 We also observed higher prevalence of symptoms of apathy
in our patients, as also described previously.29
Pain and discomfort are common symptoms among patients with
focal dystonia.11 Most of our patients presented pain, and, in most cases,
this was related to the body region affected by dystonic movements, as
already described in other studies.5 Pain is usually evident in the body
region affected by dystonia; however, pain levels do not always correlate
with the objective severity of neurological signs, as we also observed in
our sample.30 However, treatment of dystonia through local injections of
Table 2. Demographic and Clinical Characteristics of Subgroups of Patients with Focal and Segmental Idiopathic Dystonia and 80 Control
Subjects
Group 1 Group 2 Group 3 Group 4 dF F p
Number 28 28 24 80
Gender (M/F) 23/5 20/8 8/16a 29/51 0.002
Age (years) 66.6¡9.1a 57.0¡13.1 51.7¡16.1 56.5¡13.3 0.001
Schooling (years) 5.1¡5.6a 10.5¡6.5 11.9¡3.6 9.5¡4.8 0.001
MMSE 26.1¡0.6 26.1¡0.5 26.5¡0.5 26.5¡0.3 3 0.259 0.854
BDI 16.8¡2.3 10.4¡1.8 9.4¡1.9 8.7¡1.0 3 3.348 0.021a
BAI 12.2¡2.2 10.1¡1.8 6.2¡1.9 5.6¡1.0 3 3.373 0.020a
AS 16.2¡1.9 14.1¡1.6 11.1¡1.6 10.2¡0.8 3 3.486 0.017a
SPIN 15.6¡3.2 18.3¡2.6 13.6¡2.8 13.8¡1.5 3 0.812 0.489
ESS 9.0¡1.2 7.4¡1.0 8.3¡1.1 8.6¡0.6 3 0.458 0.712










































Abbreviations: AS, Apathy Scale; BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; dF, degrees of freedom; ESS, Epworth Sleepiness Scale;
F, multivariate F value; MMSE, Mini Mental State Examination; PSQI, Pittsburgh Sleep Quality Index; SPIN, Social Phobia Inventory; WHOQOL-
BREF, World Health Organization Quality of Life Brief Scale.
Date were compared using multivariate analysis of covariance.
Group 1, blepharospasm patients; group 2, cervical dystonia patients; group 3, writer’s cramp patients; group 4, control subjects.
ap # 0.05.
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botulinum toxin clearly reduces pain in these patients.31 Some studies
have suggested that pain thresholds are lower in patients with dystonia
than in healthy controls.32
Voxel-based analyses showed a reduction in gamma-aminobutyric
acid (GABA) receptor expression in the primary motor cortex, pre-
motor cortex, secondary somatosensory cortex, and motor component
of the cingulate gyrus in patients with early-onset generalized torsion
dystonia (DYT-TOR1A) and sporadic dystonia that could lead to a
lower threshold for pain.33 We observed in our sample that more than
half of our patients with blepharospasm also complained of pain that
was unrelated to the site of dystonia. This finding might be related to
the fact that these patients were older than the others, and other causes
of pain associated with aging could be responsible for these symptoms.
Further studies to clarify the mechanisms of pain associated with
dystonia are needed.
Our patients presented lower sleep quality than that of the control
subjects. Nevertheless, they did not show higher rates of daytime sleep-
iness. Other studies found the same results.11,34,35 The authors of a
systematic review on sleep disorders in cases of dystonia suggested that
sleep disturbances among these patients could have many origins, such
as the same pathophysiological mechanisms that produce dystonia,
medications, pain, the abnormal movements themselves, or psycho-
social stress.36 In our sample, symptoms of anxiety and depression
especially influenced sleep quality, but not pain or the use of anti-
depressants. Our findings support the hypothesis that psychiatric
disorders may be a significant factor related to the worsened quality of
sleep of patients with dystonia.
One of the major difficulties in studying non-motor symptoms in
movement disorders is the high prevalence of comorbidities and the
interaction between these diseases and their symptoms. Just as insomnia
can be a disease by itself, it can also be a symptom of depression or
secondary to pain. Studying various non-motor symptoms together may
be one way to evaluate these interactions and better understand what
would be related to the pathophysiology of dystonia and what would be
the consequence of this chronic disease.
Patients with dystonia may present non-motor symptoms for several
reasons. In addition, some non-motor symptoms may interact with
each other to cause or worsen other symptoms. Some of these might
mainly be consequences of psychosocial effects relating to dystonia
itself; however, dysfunctions in the basal ganglia circuits could be the
cause of several of these non-motor symptoms.
We did not design our study to answer these questions, and further
studies are needed in order to understand the mechanisms underlying
these effects. However, our findings suggest that physical alterations caused
by dystonia might also have been responsible for some of our patients’
psychiatric complaints, as such complaints were more frequent among
patients with blepharospasm and cervical dystonia than among those with
writer’s cramp. Among patients with blepharospasm, some authors have
suggested that depression may be a cause of the facial feedback.37
A recent study sought to assess correlations between psychiatric
symptoms and dopaminergic dysfunction in movement disorders. It
was found that patients with dystonia presented an inverse association
between the severity of depressive and anxiety symptoms and the
availability of dopaminergic transporter in the left putamen.38
Striatum connections such as the prefrontal cortex, amygdala, and
locus coeruleus connect neuronal networks relating to the pathophy-
siology of anxiety. Thus, it is possible that the psychiatric symptoms
found in these patients were, in part, secondary to striatal pathway
dysfunction. It can therefore be seen that the pathophysiology of non-
motor symptoms in cases of dystonia is complex and depends on the
interplay between various clinical factors and underlying abnormalities
of the functioning of the basal ganglia.
Nevertheless, the negative impact of non-motor symptoms on the
quality of life indicates the importance of investigating their presence
in patients with dystonia, in order to plan individualized treatments. As
shown in previous studies, we also observed that patients with common
focal dystonia presented worse quality of life than that of control
subjects.4,39 The domains most affected were physical and psycholo-
gical. The severity of motor symptoms as measured using the Fahn–
Marsden Dystonia Rating Scale was not a relevant predictor of quality
of life in the way that some non-motor symptoms were, especially pain
and depression. Additionally, we observed that there was a difference
in the quality of life depending on the clinical form of focal dystonia.
We believe that discrimination through these non-motor symptoms
explains this observation.
This study was the first Brazilian study evaluating and correlating
the non-motor symptoms among patients with idiopathic focal and
segmental dystonia. We included a relatively large and selected
sample, and used clinical scales that had been validated for the
Brazilian population. However, we only included a small number of
patients with each different subtype of dystonia and the patients were
not subjected to psychiatric evaluation or polysomnography for a more
detailed clinical analysis.
In conclusion, our study reinforces previous observations, thus
indicating that there was higher prevalence of symptoms of depression,
anxiety, apathy and pain, and poorer quality of sleep, among patients
with focal dystonia. This study also showed that these symptoms could
influence one another.
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